Control strategy for biopharmaceutical production by model predictive control
Biotechnology Progress · 2024-03 · 40 (2)
DOI: 10.1002/btpr.3426 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Progress, online erschienen am 10.01.2024. Verfasst von Touraj Eslami und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria. Hauptthemen laut MEDLINE: Biological Products. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 251 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, Österreichische Forschungsförderungsgesellschaft.
Abstract (Originalsprache)
The biopharmaceutical industry is rapidly advancing, driven by the need for cutting‐edge technologies to meet the growing demand for life‐saving treatments. In this context, Model Predictive Control (MPC) has emerged as a promising solution to address the complexity of modern biopharmaceutical production processes. Its ability to optimize operations and ensure consistent product yields has made it an attractive option for manufacturers in this sector. Furthermore, MPC's alignment with the Process Analytical Technology (PAT) initiative provides an additional layer of assurance, facilitating real‐time monitoring and enabling swift adjustments to maintain process integrity. This comprehensive review delves into the various applications of MPC, ranging from robust control to stochastic model predictive control, thereby equipping biotechnologists and process engineers with a powerful toolset. By harnessing the capabilities of MPC, as elucidated in this review, manufacturers can confidently navigate the intricate bioprocessing landscape and unlock this approach's full potential in their production processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.
- Austrian Centre of Industrial Biotechnology, Vienna, Austria.
- Evon GmbH, St. Ruprecht an der Raab, Austria.
ORCID-Profile: Touraj Eslami, Alois Jungbauer
Förderung
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- Österreichische Forschungsförderungsgesellschaft
Zitieren
APA
Eslami, T., & Jungbauer, A. (2024). Control strategy for biopharmaceutical production by model predictive control. Biotechnology Progress, 40(2). https://doi.org/10.1002/btpr.3426
Vancouver
Eslami T, Jungbauer A. Control strategy for biopharmaceutical production by model predictive control. Biotechnology Progress. 2024;40(2). doi:10.1002/btpr.3426
BibTeX
@article{Eslami2024,
author = {Eslami, Touraj and Jungbauer, Alois},
title = {Control strategy for biopharmaceutical production by model predictive control},
journal = {Biotechnology Progress},
year = {2024},
volume = {40},
number = {2},
doi = {10.1002/btpr.3426}
}
EUVIMED